Patents by Inventor Eileen T. Duenas

Eileen T. Duenas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release microencapsulated NGF formulation
    Patent number: 7163701
    Abstract: NGF microencapsulation compositions having controlled release characteristics, preferably with increased stability, for the NGF component, particularly human recombinant NGF (“rhNGF”) are provided that yield enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function. Methods for making and using such compositions are also provided.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: January 16, 2007
    Assignee: Genentech, Inc.
    Inventors: Jeffrey L. Cleland, Xanthe M. Lam, Eileen T. Duenas
  • Controlled release microencapsulated NGF formulation
    Patent number: 6663899
    Abstract: NGF microencapsulation compositions having controlled release characteristics, preferably with increased stability, for the NGF component, particularly human recombinant NGF (“rhNGF”) are provided that yield enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function. Methods for making and using such compositions are also provided.
    Type: Grant
    Filed: June 11, 1998
    Date of Patent: December 16, 2003
    Assignee: Genentech, Inc.
    Inventors: Jeffrey L. Cleland, Xanthe M. Lam, Eileen T. Duenas
  • Controlled release microencapsulated NGF formulation
    Publication number: 20030203040
    Abstract: NGF microencapsulation compositions having controlled release characteristics, preferably with increased stability, for the NGF component, particularly human recombinant NGF (“rhNGF”) are provided that yield enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function. Methods for making and using such compositions are also provided.
    Type: Application
    Filed: May 20, 2003
    Publication date: October 30, 2003
    Inventors: Jeffrey L. Cleland, Xanthe M. Lam, Eileen T. Duenas
  • CONTROLLED RELEASE MICROENCAPSULATED NGF FORMULATION
    Publication number: 20020004481
    Abstract: NGF microencapsulation compositions having controlled release characteristics, preferably with increased stability, for the NGF component, particularly human recombinant NGF (“rhNGF”) are provided that yield enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function. Methods for making and using such compositions are also provided.
    Type: Application
    Filed: June 11, 1998
    Publication date: January 10, 2002
    Inventors: JEFFREY L. CLELAND, XANTHE M. LAM, EILEEN T. DUENAS
  • Controlled release microencapsulated NGF formulation
    Patent number: 6113947
    Abstract: NGF microencapsulation compositions having controlled release characteristics, preferably with increased stability, for the NGF component, particularly human recombinant NGF ("rhNGF") are provided that yield enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function. Methods for making and using such compositions are also provided.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: September 5, 2000
    Assignee: Genentech, Inc.
    Inventors: Jeffrey L. Cleland, Xanthe M. Lam, Eileen T. Duenas